Regroel-po

Regroel-po has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 24, 2026: “Nanoparticle vaccine candidate protected adult and aged mice”.

Intervention

1 paper studies it4 findingsUpdated Sep 29, 2026

1 new paper in 30 daysSee all 1

None of its findings points the other way.

1 lab in 1 country

Funders: National Key Research and Development Program of China and 1 more

Animals1

What did studies of Regroel-po find?

Studies of Regroel-po measured 4 outcomes; the most studied are pseudomonas aeruginosa pneumonia (1 study), immune responses (1) and dendritic-cell maturation (1).

Pseudomonas aeruginosa pneumonia

downin mice1

1 study

Regroel-po protects against pseudomonas aeruginosa pneumonia in mice.
“reGroEL-PO elicited immune responses and conferred protection in adult and aged mice.”
Animals
Nanoparticle vaccine candidate protected adult and aged mice
ACS nanoSep 29, 2026

More on Pseudomonas aeruginosa pneumonia

Immune responses

upin mice1

1 study

Regroel-po induces immune responses in mice.
“reGroEL-PO elicited immune responses and conferred protection in adult and aged mice.”
Animals
Nanoparticle vaccine candidate protected adult and aged mice
ACS nanoSep 29, 2026

Dendritic-cell maturation

upin mice1

1 study

Regroel-po increases dendritic-cell maturation in mice.
“reGroEL-PO increased antigen uptake by antigen-presenting cells, promoted dendritic-cell maturation”
Animalsdendritic cell
Nanoparticle vaccine candidate protected adult and aged mice
ACS nanoSep 29, 2026

Antigen uptake

upin mice1

1 study

Regroel-po increases antigen uptake in mice.
“reGroEL-PO increased antigen uptake by antigen-presenting cells”
Animalsantigen-presenting cell
Nanoparticle vaccine candidate protected adult and aged mice
ACS nanoSep 29, 2026

Latest

1 paper in 12 months

ACS NanoOct 24

Nanoparticle vaccine candidate protected adult and aged mice

In mouse experiments, pre-existing immunity to the vaccine’s protein scaffold enhanced responses to the attached bacterial antigens rather than weakening them.In mouse experiments, pre-existing immunity to the vaccine’s protein scaffold enhanced responses to the attached bacterial antigens rather than weakening them.

Mouse studyInterventions

Paper

Regroel-po

What did studies of Regroel-po find?

Latest

Nanoparticle vaccine candidate protected adult and aged mice

Related